Physician

Hala M Alshayeb, MD

According to 2025 Medicare claims, Hala Alshayeb, MD (NPI: 1942400452) practices nephrology in the Huntington-Ashland, WV-KY-OH market, with the plurality of this provider's patient population coming from Greenup, KY. This provider's primary affiliated billing organization is KINGS DAUGHTERS MEDICAL SPECIALTIES INC (NPI: 1184912453; TIN: 264183569) and primary practice location at 41101-2843.

Alshayeb's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 363 traditional Medicare patients, billed 1,162 HCPCS/CPT codes, and received $88,758 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 594 prescription claims across 163 beneficiaries totaling $44,699 in drug costs, led by Farxiga (Dapagliflozin Propanediol). DME data shows 52 claims. Open Payments data shows 36 records totaling $731. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $82,043 and ending at $88,758. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $55,177 and ending at $44,699. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $0 to $3,228.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	397	1,417	$82,043
2016	334	1,049	$72,975
2017	381	2,405	$97,414
2018	212	488	$32,163
2019	333	1,112	$65,793
2020	326	1,202	$77,927
2021	268	1,046	$72,073
2022	185	727	$47,313
2023	279	901	$74,478
2024	363	1,162	$88,758

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	165	1,089	$55,177
2016	203	1,846	$160,456
2017	204	1,895	$174,179
2018	155	897	$102,538
2019	106	242	$13,691
2020	91	234	$10,818
2021	66	154	$9,024
2022	42	101	$6,331
2023	107	491	$26,242
2024	163	594	$44,699

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	43	$1,111
2021	N/R	72	$3,806
2022	N/R	86	$4,135
2023	N/R	88	$4,391
2024	N/R	52	$2,919

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	103	104	$121
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	45	72	$87
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	58	58	$81
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	84	107	$70
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	203	668	$58

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Farxiga	Dapagliflozin Propanediol	19	750	$13,824
Sevelamer Carbonate	Sevelamer Carbonate	17	810	$1,122
Labetalol Hcl	Labetalol Hcl	30	1,630	$697
Hydralazine Hcl	Hydralazine Hcl	36	2,130	$473
Tamsulosin Hcl	Tamsulosin Hcl	22	1,140	$272

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	32	$2,652
E0431	Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing	Y	N/R	20	$267

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	36	$731	Bayer Healthcare Pharmaceuticals Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Hala M. Alshayeb, MD?

Tedicare shows public-source Medicare data for Hala M. Alshayeb, MD (NPI 1942400452), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Hala M. Alshayeb, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Hala M. Alshayeb, MD?

Hala M. Alshayeb, MD is linked to KINGS DAUGHTERS MEDICAL SPECIALTIES INC (billing NPI 1184912453) in the available physician profile data.

Does Hala M. Alshayeb, MD have Open Payments data?

Hala M. Alshayeb, MD has 36 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.